Abhishek Mahajan MD, Presenter: Nothing to Disclose

Sandip Basu MBBS, MD, Abstract Co-Author: Nothing to Disclose

Meenakshi Haresh Thakur MD, Abstract Co-Author: Nothing to Disclose

Molecular functional imaging has given a newer insight to the medical imaging and has diversified the role of imaging in the field of the translational cancer medicine and has an indispensible role to play in screening, early diagnosis, staging, predicting prognosis, therapy delivery, therapy monitoring and follow-up. Overall there has been a significant development in the field of molecular imaging and its utilisation in the perspective of the biomedical research which has led to better understanding of the signalling pathways in the tumorigenesis and novel drug discoveries. The future of molecular functional imaging in the coming era is its exploitation into understanding the gene expression profiling in-vivo and optimising the patient specific therapies using gene expression profiling. Quantitative molecular functional imaging, in conjunction with quantitative structural imaging, will be the future of "personalized radiology," "personalized oncology," "personalized medicine," and of oncologic research in the 21st century and beyond. 

• Cancer And Molecular Functional Imaging (MFI) • MFI Of Gene Expression, Receptors And Signalling Pathways • MFI of Multidrug-Resistance In Cancer • MFI Of Extracellular Matrix And Its Key Components • MFI Of Neoangiogenesis, Hypoxia And Metabolism • MFI And Small Animal Imaging  

http://abstract.rsna.org/uploads/2014/14006178/14006178_t4tv.pdf

Mahajan, A, Basu, S, Thakur, M, A Review of Bench to Bedside Molecular Functional Imaging in Translational Cancer Medicine: To Image or to Imagine? [ MI Scavenger Hunt! ].  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14006178.html